P
PharmaResearch Co Ltd
KOSDAQ:214450
PharmaResearch Co Ltd
KOSDAQ:214450
Price:
410 000
KRW
-3.19%
Market Cap:
4.3T
KRW
Income Statement
Earnings Waterfall
PharmaResearch Co Ltd
PharmaResearch Co Ltd
|
Revenue
|
350.1B
KRW
|
|
Cost of Revenue
|
-98.9B
KRW
|
|
Gross Profit
|
251.2B
KRW
|
|
Operating Expenses
|
-125.2B
KRW
|
|
Operating Income
|
126.1B
KRW
|
|
Other Expenses
|
-34B
KRW
|
|
Net Income
|
92B
KRW
|
Income Statement
PharmaResearch Co Ltd
PharmaResearch Co Ltd
Currency: KRW
Millions
TTM
| Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
286
|
0
|
0
|
0
|
459
|
97
|
0
|
107
|
27
|
17
|
20
|
11
|
8
|
20
|
281
|
541
|
804
|
1 000
|
1 980
|
2 199
|
2 343
|
2 545
|
1 718
|
1 764
|
1 787
|
1 720
|
1 467
|
1 090
|
1 314
|
1 863
|
2 663
|
3 437
|
3 830
|
4 194
|
3 969
|
3 533
|
2 987
|
2 481
|
0
|
0
|
4 634
|
|
| Revenue |
24 765
N/A
|
28 237
+14%
|
31 577
+12%
|
34 543
+9%
|
37 455
+8%
|
40 854
+9%
|
43 810
+7%
|
45 094
+3%
|
45 953
+2%
|
46 580
+1%
|
47 240
+1%
|
50 614
+7%
|
54 470
+8%
|
56 518
+4%
|
60 777
+8%
|
61 865
+2%
|
64 281
+4%
|
70 242
+9%
|
73 324
+4%
|
77 416
+6%
|
83 872
+8%
|
84 091
+0%
|
91 747
+9%
|
101 283
+10%
|
108 746
+7%
|
122 609
+13%
|
133 706
+9%
|
143 282
+7%
|
154 083
+8%
|
164 813
+7%
|
175 719
+7%
|
183 191
+4%
|
194 759
+6%
|
204 932
+5%
|
222 030
+8%
|
244 661
+10%
|
261 011
+7%
|
280 285
+7%
|
296 594
+6%
|
316 997
+7%
|
350 115
+10%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(6 555)
|
(7 830)
|
(9 611)
|
(10 579)
|
(11 687)
|
(12 644)
|
(12 999)
|
(14 187)
|
(15 116)
|
(15 612)
|
(16 131)
|
(17 038)
|
(18 405)
|
(19 216)
|
(21 862)
|
(23 409)
|
(26 064)
|
(28 623)
|
(30 954)
|
(33 140)
|
(33 766)
|
(33 603)
|
(34 271)
|
(35 024)
|
(35 850)
|
(38 538)
|
(40 183)
|
(42 495)
|
(45 750)
|
(49 113)
|
(51 440)
|
(52 202)
|
(53 246)
|
(54 915)
|
(58 063)
|
(63 915)
|
(70 753)
|
(78 668)
|
(85 590)
|
(92 009)
|
(98 878)
|
|
| Gross Profit |
18 210
N/A
|
20 408
+12%
|
21 967
+8%
|
23 965
+9%
|
25 768
+8%
|
28 210
+9%
|
30 811
+9%
|
30 907
+0%
|
30 837
0%
|
30 968
+0%
|
31 109
+0%
|
33 577
+8%
|
36 065
+7%
|
37 303
+3%
|
38 916
+4%
|
38 456
-1%
|
38 217
-1%
|
41 620
+9%
|
42 371
+2%
|
44 277
+4%
|
50 106
+13%
|
50 488
+1%
|
57 476
+14%
|
66 258
+15%
|
72 896
+10%
|
84 070
+15%
|
93 522
+11%
|
100 787
+8%
|
108 333
+7%
|
115 701
+7%
|
124 280
+7%
|
130 989
+5%
|
141 513
+8%
|
150 018
+6%
|
163 967
+9%
|
180 746
+10%
|
190 258
+5%
|
201 617
+6%
|
211 004
+5%
|
224 988
+7%
|
251 237
+12%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(6 795)
|
(7 045)
|
(7 944)
|
(8 201)
|
(9 674)
|
(12 377)
|
(13 960)
|
(14 210)
|
(16 732)
|
(15 272)
|
(15 728)
|
(17 083)
|
(21 222)
|
(24 021)
|
(26 780)
|
(30 758)
|
(29 512)
|
(33 589)
|
(30 956)
|
(30 620)
|
(31 044)
|
(31 783)
|
(34 868)
|
(37 797)
|
(39 470)
|
(44 155)
|
(47 738)
|
(50 830)
|
(55 844)
|
(61 109)
|
(66 208)
|
(70 050)
|
(75 597)
|
(83 708)
|
(91 402)
|
(97 204)
|
(98 001)
|
(106 550)
|
(108 823)
|
(115 379)
|
(125 187)
|
|
| Selling, General & Administrative |
(4 409)
|
(4 817)
|
(5 883)
|
(6 252)
|
(7 439)
|
(9 862)
|
(10 874)
|
(11 369)
|
(12 844)
|
(11 302)
|
(10 914)
|
(11 366)
|
(16 127)
|
(17 283)
|
(20 435)
|
(23 398)
|
(21 213)
|
(22 809)
|
(21 449)
|
(20 827)
|
(20 536)
|
(21 379)
|
(24 260)
|
(26 711)
|
(28 535)
|
(31 034)
|
(33 691)
|
(36 760)
|
(42 762)
|
(46 882)
|
(51 123)
|
(53 941)
|
(59 651)
|
(61 367)
|
(67 182)
|
(71 841)
|
(75 095)
|
(79 359)
|
(80 270)
|
(84 434)
|
(95 044)
|
|
| Research & Development |
(1 899)
|
(1 624)
|
(1 615)
|
(1 569)
|
(1 763)
|
(2 013)
|
(2 578)
|
(2 309)
|
(3 378)
|
(3 447)
|
(4 269)
|
(5 150)
|
(4 497)
|
(5 206)
|
(4 529)
|
(4 379)
|
(4 043)
|
(4 177)
|
(4 368)
|
(4 824)
|
(5 614)
|
(5 569)
|
(5 386)
|
(5 673)
|
(5 543)
|
(6 167)
|
(6 793)
|
(6 581)
|
(6 738)
|
(7 002)
|
(7 578)
|
(8 305)
|
(8 702)
|
(9 706)
|
(11 481)
|
(12 506)
|
(15 030)
|
(16 189)
|
(17 727)
|
(19 946)
|
(21 176)
|
|
| Depreciation & Amortization |
(487)
|
(575)
|
(417)
|
(351)
|
(471)
|
(497)
|
(504)
|
(529)
|
(510)
|
(523)
|
(543)
|
(566)
|
(597)
|
(649)
|
(1 815)
|
(2 980)
|
(4 257)
|
(5 570)
|
(5 143)
|
(4 973)
|
(4 894)
|
(4 837)
|
(5 224)
|
(5 414)
|
(5 392)
|
(5 704)
|
(6 009)
|
(6 244)
|
(6 344)
|
(6 385)
|
(6 715)
|
(7 013)
|
(7 384)
|
(7 711)
|
(7 767)
|
(7 885)
|
(8 003)
|
(8 171)
|
(8 222)
|
(8 394)
|
(8 966)
|
|
| Other Operating Expenses |
0
|
(29)
|
(29)
|
(29)
|
0
|
(5)
|
(4)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
(883)
|
0
|
0
|
0
|
(1 033)
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
(1 250)
|
(1 245)
|
(1 245)
|
0
|
(840)
|
(792)
|
(792)
|
140
|
(4 924)
|
(4 972)
|
(4 972)
|
128
|
(2 831)
|
(2 605)
|
(2 605)
|
0
|
|
| Operating Income |
11 413
N/A
|
13 361
+17%
|
14 022
+5%
|
15 763
+12%
|
16 094
+2%
|
15 833
-2%
|
16 850
+6%
|
16 696
-1%
|
14 105
-16%
|
15 695
+11%
|
15 382
-2%
|
16 494
+7%
|
14 843
-10%
|
13 283
-11%
|
12 136
-9%
|
7 699
-37%
|
8 705
+13%
|
8 030
-8%
|
11 414
+42%
|
13 656
+20%
|
19 062
+40%
|
18 706
-2%
|
22 609
+21%
|
28 463
+26%
|
33 426
+17%
|
39 917
+19%
|
45 786
+15%
|
49 958
+9%
|
52 489
+5%
|
54 592
+4%
|
58 071
+6%
|
60 939
+5%
|
65 916
+8%
|
66 309
+1%
|
72 565
+9%
|
83 541
+15%
|
92 258
+10%
|
95 067
+3%
|
102 181
+7%
|
109 609
+7%
|
126 051
+15%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(304)
|
(330)
|
(453)
|
(132)
|
168
|
1 813
|
3 455
|
4 165
|
3 308
|
2 250
|
1 740
|
1 319
|
1 861
|
2 100
|
3 204
|
2 874
|
650
|
1 232
|
(1 359)
|
(918)
|
73
|
(154)
|
(81)
|
(866)
|
3 382
|
3 146
|
3 848
|
5 993
|
4 030
|
2 555
|
(2 426)
|
(1 314)
|
(6 668)
|
(3 937)
|
960
|
4 686
|
12 355
|
7 014
|
13 792
|
4 002
|
(9 344)
|
|
| Non-Reccuring Items |
(29)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(881)
|
0
|
(1 917)
|
(1 917)
|
(868)
|
0
|
0
|
0
|
67
|
0
|
(6)
|
(6)
|
(1 251)
|
0
|
0
|
0
|
(840)
|
0
|
0
|
0
|
(5 111)
|
0
|
0
|
0
|
(3 120)
|
0
|
0
|
0
|
(455)
|
|
| Gain/Loss on Disposition of Assets |
(15)
|
(5)
|
(5)
|
(5)
|
(1)
|
(4)
|
(7)
|
(49)
|
(60)
|
(87)
|
(89)
|
(59)
|
(84)
|
0
|
(187)
|
(396)
|
(495)
|
0
|
(513)
|
(473)
|
(325)
|
0
|
0
|
(231)
|
(363)
|
0
|
0
|
0
|
230
|
254
|
290
|
245
|
(114)
|
(88)
|
(127)
|
(83)
|
36
|
(6)
|
(1)
|
(1)
|
(12)
|
|
| Total Other Income |
26
|
21
|
(49)
|
(42)
|
(73)
|
(95)
|
(92)
|
(92)
|
(28)
|
(17)
|
(327)
|
(328)
|
(344)
|
(405)
|
(607)
|
(708)
|
6 373
|
5 430
|
6 481
|
6 662
|
(348)
|
(277)
|
4 443
|
4 432
|
4 343
|
4 256
|
(290)
|
88
|
124
|
22
|
64
|
2
|
25
|
71
|
(643)
|
(561)
|
(825)
|
(938)
|
(155)
|
(1 059)
|
(428)
|
|
| Pre-Tax Income |
11 091
N/A
|
13 047
+18%
|
13 516
+4%
|
15 585
+15%
|
16 185
+4%
|
17 547
+8%
|
20 205
+15%
|
20 719
+3%
|
17 325
-16%
|
17 842
+3%
|
16 706
-6%
|
17 426
+4%
|
15 396
-12%
|
14 978
-3%
|
12 628
-16%
|
7 551
-40%
|
14 364
+90%
|
14 692
+2%
|
16 023
+9%
|
18 927
+18%
|
18 529
-2%
|
18 275
-1%
|
26 965
+48%
|
31 791
+18%
|
39 537
+24%
|
47 319
+20%
|
49 345
+4%
|
56 038
+14%
|
56 033
0%
|
57 423
+2%
|
55 999
-2%
|
59 872
+7%
|
54 048
-10%
|
62 356
+15%
|
72 754
+17%
|
87 583
+20%
|
100 705
+15%
|
101 137
+0%
|
115 817
+15%
|
112 551
-3%
|
115 813
+3%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(2 253)
|
(2 633)
|
(2 884)
|
(3 277)
|
(3 308)
|
(3 553)
|
(3 830)
|
(4 056)
|
(3 498)
|
(3 613)
|
(3 478)
|
(3 219)
|
(2 879)
|
(2 795)
|
(2 955)
|
(2 840)
|
(3 099)
|
(3 285)
|
(2 726)
|
(2 697)
|
(3 678)
|
(3 604)
|
(5 787)
|
(6 579)
|
(7 085)
|
(6 697)
|
(6 511)
|
(7 152)
|
(9 210)
|
(13 088)
|
(13 642)
|
(14 193)
|
(10 614)
|
(10 446)
|
(15 440)
|
(18 683)
|
(23 440)
|
(23 895)
|
(25 039)
|
(24 456)
|
(26 870)
|
|
| Income from Continuing Operations |
8 837
|
10 414
|
10 631
|
12 307
|
12 878
|
13 993
|
16 375
|
16 664
|
13 827
|
14 229
|
13 228
|
14 206
|
12 517
|
12 183
|
9 673
|
4 711
|
11 265
|
11 406
|
13 296
|
16 229
|
14 851
|
14 671
|
21 178
|
25 212
|
32 452
|
40 623
|
42 834
|
48 886
|
46 824
|
44 335
|
42 357
|
45 680
|
43 434
|
51 910
|
57 314
|
68 900
|
77 265
|
77 243
|
90 778
|
88 094
|
88 943
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
60
|
82
|
149
|
245
|
317
|
439
|
397
|
1 463
|
2 203
|
3 143
|
3 904
|
3 087
|
2 831
|
1 817
|
1 736
|
1 930
|
1 790
|
322
|
(470)
|
(1 300)
|
(1 775)
|
(135)
|
(583)
|
9
|
821
|
(2 857)
|
(2 946)
|
(1 699)
|
(3 998)
|
(713)
|
(1 151)
|
(34)
|
663
|
3 100
|
|
| Net Income (Common) |
8 837
N/A
|
10 413
+18%
|
10 629
+2%
|
12 305
+16%
|
12 878
+5%
|
13 993
+9%
|
16 375
+17%
|
16 725
+2%
|
13 909
-17%
|
14 378
+3%
|
13 473
-6%
|
14 523
+8%
|
12 956
-11%
|
12 580
-3%
|
11 135
-11%
|
6 914
-38%
|
14 408
+108%
|
15 311
+6%
|
16 385
+7%
|
19 061
+16%
|
16 667
-13%
|
16 408
-2%
|
23 109
+41%
|
27 003
+17%
|
32 774
+21%
|
40 152
+23%
|
41 533
+3%
|
47 109
+13%
|
46 689
-1%
|
43 752
-6%
|
42 366
-3%
|
46 501
+10%
|
40 577
-13%
|
48 964
+21%
|
55 615
+14%
|
64 902
+17%
|
76 551
+18%
|
76 092
-1%
|
90 744
+19%
|
88 757
-2%
|
92 043
+4%
|
|
| EPS (Diluted) |
1 262.42
N/A
|
1 487.57
+18%
|
1 518.42
+2%
|
1 757.85
+16%
|
1 609.75
-8%
|
1 554.77
-3%
|
1 819.44
+17%
|
1 858.33
+2%
|
1 545.44
-17%
|
1 597.55
+3%
|
1 497
-6%
|
1 613.66
+8%
|
1 439.55
-11%
|
1 258
-13%
|
1 237.22
-2%
|
768.22
-38%
|
1 440.8
+88%
|
1 531.1
+6%
|
1 820.55
+19%
|
2 117.88
+16%
|
1 851.88
-13%
|
1 823.11
-2%
|
2 310.9
+27%
|
2 700.3
+17%
|
3 277.4
+21%
|
4 063.45
+24%
|
4 163.31
+2%
|
4 722.28
+13%
|
4 644.41
-2%
|
4 149.42
-11%
|
4 018
-3%
|
4 410.17
+10%
|
3 848.31
-13%
|
4 638.18
+21%
|
5 236.01
+13%
|
6 155.34
+18%
|
7 249.68
+18%
|
7 205.61
-1%
|
8 593.11
+19%
|
8 404.95
-2%
|
8 940.87
+6%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
